JP2022543230A5 - - Google Patents

Info

Publication number
JP2022543230A5
JP2022543230A5 JP2022506568A JP2022506568A JP2022543230A5 JP 2022543230 A5 JP2022543230 A5 JP 2022543230A5 JP 2022506568 A JP2022506568 A JP 2022506568A JP 2022506568 A JP2022506568 A JP 2022506568A JP 2022543230 A5 JP2022543230 A5 JP 2022543230A5
Authority
JP
Japan
Prior art keywords
phenyl
ethyl
hydroxy
trifluoromethoxy
pentanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506568A
Other languages
English (en)
Japanese (ja)
Other versions
JP7591036B2 (ja
JP2022543230A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/071514 external-priority patent/WO2021023616A1/en
Publication of JP2022543230A publication Critical patent/JP2022543230A/ja
Publication of JP2022543230A5 publication Critical patent/JP2022543230A5/ja
Application granted granted Critical
Publication of JP7591036B2 publication Critical patent/JP7591036B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506568A 2019-08-02 2020-07-30 てんかん又はてんかん発作において使用するためのKv7カリウムチャネル開口薬としてのアルコール誘導体 Active JP7591036B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19189744.6 2019-08-02
EP19189744 2019-08-02
PCT/EP2020/071514 WO2021023616A1 (en) 2019-08-02 2020-07-30 Alcohol derivatives as kv7 potassium channel openers for use in epilepsy or seizures

Publications (3)

Publication Number Publication Date
JP2022543230A JP2022543230A (ja) 2022-10-11
JP2022543230A5 true JP2022543230A5 (https=) 2023-08-04
JP7591036B2 JP7591036B2 (ja) 2024-11-27

Family

ID=67539335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506568A Active JP7591036B2 (ja) 2019-08-02 2020-07-30 てんかん又はてんかん発作において使用するためのKv7カリウムチャネル開口薬としてのアルコール誘導体

Country Status (6)

Country Link
US (1) US12508239B2 (https=)
EP (1) EP4007571B1 (https=)
JP (1) JP7591036B2 (https=)
CN (2) CN114206328B (https=)
ES (1) ES3034153T3 (https=)
WO (1) WO2021023616A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
RS66130B1 (sr) * 2019-08-02 2024-11-29 H Lundbeck As Derivati alkohola kao otvarači kv7 kalijumovih kanala

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915414D0 (en) 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
WO2001092526A1 (en) 2000-05-26 2001-12-06 Bristol-Myers Squibb Company Human kcnq5 potassium channel, methods and compositions thereof
WO2001096540A2 (en) 2000-06-11 2001-12-20 Dupont Pharmaceuticals Company Hepatitis c protease exosite for inhibitor design
US7091202B2 (en) 2004-09-15 2006-08-15 Bristol-Myers Squibb Company 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
KR20080043314A (ko) * 2005-09-09 2008-05-16 하. 룬트벡 아크티에 셀스카브 피리미딘 유도체 및 kcnq 포타슘 채널 개방제로서의그의 용도
WO2007057447A1 (en) 2005-11-18 2007-05-24 Neurosearch A/S Novel quinazoline derivatives and their medical use
TWI453013B (zh) 2006-02-07 2014-09-21 Lundbeck & Co As H N-(2,4-二甲基-6-嗎啉-4-基-吡啶-3-基〉3,3-二甲基-丁醯胺之用途以及包含該化合物之醫藥品
WO2007104717A1 (en) 2006-03-15 2007-09-20 Neurosearch A/S Quinazolinones and their use as potassium channels activators
AR070513A1 (es) 2007-08-01 2010-04-14 Lundbeck & Co As H Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sis-tema dopaminergico como por ejemplo esquizofrenia y trastorno depresivo mayor
TW201024286A (en) 2008-11-27 2010-07-01 Neurosearch As Novel compounds
TW201041857A (en) 2009-05-11 2010-12-01 Lundbeck & Co As H Stable forms of N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
WO2014145852A2 (en) 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
SMT202300362T1 (it) 2014-09-12 2023-11-13 Biohaven Therapeutics Ltd Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7
JP2017095366A (ja) 2015-11-18 2017-06-01 持田製薬株式会社 新規ビアリールアミド誘導体
CN105663136A (zh) 2016-01-15 2016-06-15 河北中医学院 法舒地尔作为制备选择性Kv7离子通道激活剂药物的应用
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
EP4241843B1 (en) * 2018-02-20 2025-05-21 H. Lundbeck A/S Alcohol derivatives as kv7 potassium channel openers
AR119521A1 (es) 2019-08-02 2021-12-22 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7

Similar Documents

Publication Publication Date Title
JP2021532124A5 (https=)
ES2315425T3 (es) Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos.
JP2019520417A5 (https=)
JP2018505898A5 (https=)
JP2022519131A5 (https=)
JP2021534124A5 (https=)
JP2022543230A5 (https=)
JP2012515166A5 (https=)
KR101640263B1 (ko) 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
JP2008520589A5 (https=)
CN112839945A (zh) 补体因子d抑制剂的形态形式
AU2017298473A1 (en) Histone acetyltransferase activators and compositions and uses thereof
JP2012500800A (ja) 神経因性疼痛の治療法
JP2023512664A5 (https=)
JP2021152060A (ja) アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法
JP2021524453A5 (https=)
JP2014506602A5 (https=)
JP2022543203A5 (https=)
JP2024531437A5 (https=)
JP2009521417A5 (https=)
JP2022536160A5 (https=)
JP2022519274A5 (https=)
JP2017511340A (ja) ヒストンアセチルトランスフェラーゼ活性剤及びその使用
CA2779711C (en) Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
RU2005125047A (ru) Соединения карбоновых кислот